Revised EU medtech vigilance policy includes ART, IVF systems

02/1/2013 | Clinica (subscription required)

The European Commission has issued revised guidance governing its medical device vigilance programs, which will go into effect in July. The revision is meant to provide explicit language on devices used in assisted reproduction technology and in vitro fertilization procedures as well as to clarify the monitoring of devices not intended to directly affect patients.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL